FINAL DETAILS Sample Clauses

FINAL DETAILS. The Licensee shall provide the Licensor at least sixty (60) days prior to the beginning of the License Period all information then reasonably available to the Licensee pertinent to the activities to be undertaken in the Authorized Area pursuant to this License (herein "Plan Of Operation"), including, but not limited to:
View SourceView Similar (3)
FINAL DETAILS. Final room setup, equipment and catering requirements (including final numbers) must be supplied and confirmed by the Hirer at least 7 days prior to the Hire Period commencing. Any changes after this date cannot be guaranteed.
View Source
FINAL DETAILS. If this Agreement is acceptable to your organisation, please sign both copies of this letter and return one copy to the address below.
View Source
FINAL DETAILS. Full details of the event will be finalized on the Function Sheet at least 1 week prior to arrival and on finalization will be available to the client for signing. The signed Function Sheet will then become a part of this contract. Function guaranteed numbers and final menu and wine choices are required 5 working days prior to the 1st arrival date of your event. All dietary requirements are also needed at this time, should the request for dietary meals increase on the day or without prior notification, an additional charge will apply and be charged to the main account. Please be advised that if menus are not received by this date, it will be Chef’s choice.
View Source
FINAL DETAILS. You must supply details of timings, menus and dietary requirements in accordance with the timescales indicated on your Schedule. If you do not provide this information these decisions will be made for you, and charged accordingly. You must supply a name-list, in the format requested, and in accordance with the timescale indicated on your Schedule. An administration charge may be made if the information supplied is not in a usable format. Any changes to your name-list must be made by addendum, or by submitting an amended list with all the changes clearly identified.
View Source
FINAL DETAILS. Any obligation of the Company under the present contract are deemed to be binding, jointly and severally, also on its successors and assigns To this act and related formalities is applied the treatment envisaged in Article 15 and following of D.P.R. 29 September 1973 n. 601 (exemption from register taxes, stamp duties etc. in lieu of which is paid an imposta sostitutiva which is paid by the Bank of the amount of the loans disbursed each year) On top of the amount of the imposta sostitutiva paid by the Bank and therefore deducted by the same from the loan proceeds, in the percentage to be applied at the time of the disbursement, the Company undertakes to reimburse to the Bank eventual increases in said imposta, which may become due in relation to the present contract, as a consequence of subsequent law regulations. The Company hereby declares, having taking duly note of it, to wholly accept the terms and conditions of the present contract and to specifically approve in accordance with and for the effect of Article 1341 2nd paragraph of Civil Code, those as per Art 4, 5, 7, 8, 15.
View Source
FINAL DETAILS. (a) Approximately 18 weeks before departure we will send to the Group Contact the Final Details forms for your Group which must be completed in respect of each Group Member and sent to us so that we receive them no later than 16 weeks before departure. The Group Contact must also return to us at the same time: (i) A photocopy of the passport of each Group Member; and (ii) a copy of the Acknowledgement signed by each Group Member, as set out in the Schedule to this Agreement. (b) The Final Details forms are necessary to enable the Company to finalise and confirm your travel arrangements the Company reserves the right to make an administrative charge of up to $30 per Group Member should Final Details forms not be received by the required time.
View Source

Related to FINAL DETAILS

  • PERSONAL DETAILS 1.1 The maximum number of applicants who may be party to the mortgage is four. 1.2 All applicants must be a minimum of 18 years of age at completion. 1.3 The identity of each applicant or guarantor (where applicable) must be established in compliance with the current Joint Money Laundering Steering Group Guidance Notes. 1.4 The applicant must be resident in the United Kingdom, the Isle of Man, the Channel Islands or Gibraltar.

  • Legal Details All legal details and proceedings in connection with the transactions contemplated by this Agreement and the other Loan Documents shall be in form and substance satisfactory to the Agent and counsel for the Agent, and the Agent shall have received all such other counterpart originals or certified or other copies of such documents and proceedings in connection with such transactions, in form and substance satisfactory to the Agent and said counsel, as the Agent or said counsel may reasonably request.

  • Payment Details payments due to the School by Parents under this agreement or from time to time due to the School by Parents must be made to the School paid by BACS to Widford Lodge School Ltd, Account number: ▇▇▇▇▇▇▇▇, Sort Code: 60-05-13. The Parents should use the Child’s name as reference when making any payment.

  • COURSE DETAILS Note: The information provided below should be the same as that submitted to the CPE.

  • Tests and Preclinical and Clinical Trials The preclinical studies and clinical trials conducted by or, to the Company’s knowledge, on behalf of the Company, that are described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, as applicable, and are intended to be or have been submitted to FDA or other comparable governmental entities, were and, if still ongoing, are being conducted in all material respects in accordance with experimental protocols, applicable Authorizations, and Applicable Laws, including, without limitation, the Federal Food, Drug and Cosmetic Act and the rules and regulations promulgated thereunder and, for studies submitted to regulatory authorities for approval, in all material respects, current Good Clinical Practices and Good Laboratory Practices and any applicable rules and regulations of the jurisdiction in which such trials and studies are being conducted; the descriptions of the results of such studies and trials contained in the Registration Statement, the Pricing Disclosure Package and the Prospectus are, to the Company’s knowledge, accurate and complete and fairly present the data derived from such studies and trials in all material respects; except to the extent disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus, the Company is not aware of any studies or trials, the results of which the Company believes materially call into question the study or trial results described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus when viewed in the context in which such results are described and the clinical stage of development; and, except to the extent disclosed in the Registration Statement, the Pricing Disclosure Package or the Prospectus, the Company has not received any written notices or correspondence from the FDA or any governmental entity requiring the termination or suspension of any preclinical studies or clinical trials conducted by or on behalf of the Company, other than ordinary course communications with respect to modifications in connection with the design and implementation of such trials, copies of which communications have been made available to you.